date,title,source
Oct-26-18,Here's Why I'm Not Selling My Celgene Shares,Motley Fool
Oct-31-18,Today's Research Reports on Trending Tickers: bluebird bio and Sarepta Therapeutics,ACCESSWIRE
Nov-01-18,"Bluebird Bio (BLUE) Reports Q3 Loss, Tops Revenue Estimates",Zacks
Nov-01-18,Here's Why bluebird bio Jumped 13.5% Today,Motley Fool
Nov-01-18,Bluebird: 3Q Earnings Snapshot,Associated Press
Nov-01-18,bluebird bio Reports Third Quarter 2018 Financial Results and Highlights Operational Progress,Business Wire
Nov-01-18,bluebird bio to Present New Data from Early- and Late-Stage Pipeline of Investigational Gene and Cell Therapies at the American Society of Hematology Annual Meeting,Business Wire
Nov-05-18,Janney Upgrades bluebird bio Ahead Of Sickle Cell Presentation,Benzinga
Nov-06-18,Today's Research Reports on Trending Tickers: bluebird bio and Geron,ACCESSWIRE
Nov-07-18,3 Cancer Stocks to Watch in December,Motley Fool
Nov-07-18,3 Top Biotech Stocks to Buy in November,Motley Fool
Nov-09-18,Waiting for bluebird bio to Sing at ASH,Motley Fool
Nov-15-18,bluebird bio to Present at the Evercore ISI HealthCONx Conference,Business Wire
Nov-16-18,Edited Transcript of BLUE earnings conference call or presentation 2-Nov-18 12:00pm GMT,Thomson Reuters StreetEvents
Nov-16-18,"Market Trends Toward New Normal in PlayAGS, BEST, Inc. Sponsored ADR, Verrica Pharmaceuticals, Telenav, bluebird bio, and CompX International  Emerging Consolidated Expectations, Analyst Ratings",GlobeNewswire
Nov-16-18,Today's Research Reports on Trending Tickers: Intercept Pharmaceuticals and bluebird bio,ACCESSWIRE
Nov-19-18,3 High-Growth Stocks That Are Just Getting Started,Motley Fool
Nov-28-18,3 Themes To Watch As Biopharmas 'Bring Some Excitement' In Blood Cancer,Investor's Business Daily
Nov-28-18,Celgene & Bluebird's CAR T Therapy Study Completes Enrollment,Zacks
Nov-28-18,Leerink Starts Coverage Of Genetic Medicine Stocks: 'We See Commercial Execution As Increasingly Driving Returns',Benzinga
Nov-28-18,"Biotech Stock Roundup: Pipeline Updates From CELG & VRTX, ZFGN Plunges on Hold News",Zacks
Nov-30-18,bluebird bio to Host Live Webcast of Investor and Analyst Event at the 60th Annual Meeting of the American Society of Hematology,Business Wire
Dec-03-18,Celgene (CELG) Announces Various Cancer Data at ASH 2018,Zacks
Dec-04-18,Global Blood Therapeutics' Voxelotor on Faster Approval Path,Zacks
Dec-04-18,Today's Research Reports on Trending Tickers: GlaxoSmithKline and bluebird bio,ACCESSWIRE
Dec-04-18,"Amgen antibody shows promise in myeloma trial, gets FDA fast track",Reuters
Dec-06-18,Dow Drops 352 Points Because This Is Way More Than a Trade War,Barrons.com
Dec-07-18,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of bluebird bio, Inc.  BLUE",GlobeNewswire
Dec-10-18,Is bluebird bio Inc (BLUE) A Good Stock To Buy?,Insider Monkey
Dec-12-18,"INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Bluebird Bio, Inc. Investors (BLUE)",Business Wire
Dec-12-18,"bluebird bio, Inc. (NASDAQ:BLUE): Financial Strength Analysis",Simply Wall St.
Dec-14-18,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of bluebird bio, Inc.",GlobeNewswire
Dec-18-18,"INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Bluebird Bio, Inc. Investors (BLUE)",Business Wire
Dec-19-18,"Forget bluebird bio, Amgen Is a Better Biotech Stock",Motley Fool
Dec-20-18,"Bluebird Bio's Competitive Advantage Is Underappreciated, Raymond James Says In Bullish Initiation",Benzinga
Dec-24-18,"INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against bluebird bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",Business Wire
Dec-24-18,"EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against bluebird bio, Inc.  BLUE",Business Wire
Dec-26-18,"INVESTIGATION ALERT REMINDER: The Schall Law Firm Announces it is Investigating Claims Against bluebird bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",Business Wire
Dec-27-18,"ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against bluebird bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",GlobeNewswire
Dec-27-18,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of bluebird bio, Inc. (BLUE)",ACCESSWIRE
Dec-28-18,"Lifshitz & Miller LLP Announces Investigation of Bluebird Bio, Inc., Cavco Industries, Inc., Edge Therapeutics, Inc., Inuvo, Inc., Lumentum Holdings, Inc., National Commerce Corporation, and Nobilis Health Corp.",PR Newswire
Jan-03-19,"ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against bluebird bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",GlobeNewswire
Jan-03-19,bluebird bio to Present at the 37th Annual J.P. Morgan Healthcare Conference,Business Wire
Jan-04-19,Here's Why bluebird bio Shares Got Knocked Down 19.3% in December,Motley Fool
Jan-04-19,Bristol-Myers Becomes a Cancer-Fighting Giant With Celgene Buyout,InvestorPlace
Jan-04-19,Bristol-Myers to Acquire Celgene: Healthcare ETFs in Focus,Zacks
Jan-07-19,"bluebird bio and Inhibrx Announce Collaboration to Research, Develop and Commercialize CAR T Cell Immunotherapies",Business Wire
Jan-08-19,Biotech Proposes Paying for Pricey Drugs by Installment,The Wall Street Journal
Jan-08-19,Biotech Proposes Paying for Pricey Drugs by Installment,The Wall Street Journal
Jan-08-19,"Celgene (CELG) Provides Guidance for 2019, Updates Pipeline",Zacks
Jan-10-19,"Three tech, three biotech companies that are top takeover targets in 2019",MarketWatch
Jan-11-19,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Investigation Against bluebird bio, Inc. (BLUE)",ACCESSWIRE
Jan-11-19,Today's Research Reports on Trending Tickers: bluebird bio and Ultragenyx Pharmaceutical,ACCESSWIRE
Jan-22-19,Here's Why CRISPR Therapeutics Stock Fell Today,Motley Fool
Jan-23-19,5 Best Biotech Bets Likely to Outperform Estimates in Q4,Zacks
Jan-24-19,"The Zacks Analyst Blog Highlights: Celgene, Regeneron Pharmaceuticals, Amgen, Alnylam Pharmaceuticals and bluebird bio",Zacks
Jan-24-19,Where Will bluebird bio Be in 5 Years?,Motley Fool
Jan-28-19,"Did bluebird bio, Inc. (NASDAQ:BLUE) Insiders Sell Shares?",Simply Wall St.
Jan-31-19,"Celgene (CELG) Q4 Earnings Beat Estimates, Revenues Up Y/Y",Zacks
Jan-31-19,Today's Research Reports on Trending Tickers: bluebird bio and Mirati Therapeutics,ACCESSWIRE
Feb-01-19,German firm that serves gene therapy biotechs opens Cambridge HQ,American City Business Journals
Feb-06-19,"Regeneron Q4 Earnings &amp; Sales Beat on Strong Dupixent, Eylea",Zacks
Feb-11-19,bluebird bio Appoints Chip Baird as Chief Financial Officer,Business Wire
Feb-12-19,AbbVie Buys Rights to Novel Immunotherapy for Multiple Myeloma,Zacks
Feb-13-19,Earnings Preview: Bluebird Bio (BLUE) Q4 Earnings Expected to Decline,Zacks
Feb-14-19,"Report: Exploring Fundamental Drivers Behind Tyson Foods, ElectraMeccanica Vehicles, Cousins Properties, Spirit Aerosystems, bluebird bio, and Yext  New Horizons, Emerging Trends, and Upcoming Developments",GlobeNewswire
Feb-21-19,"Bluebird Bio (BLUE) Reports Q4 Loss, Tops Revenue Estimates",Zacks
Feb-21-19,Bluebird: 4Q Earnings Snapshot,Associated Press
Feb-21-19,bluebird bio Reports Fourth Quarter and Full Year 2018 Financial Results and Highlights Operational Progress,Business Wire
Feb-22-19,"bluebird (BLUE) Q4 Earnings Beat Estimates, Revenues Up Y/Y",Zacks
Feb-26-19,"With a Stocked War Chest, bluebird bio Presses On",Motley Fool
Feb-26-19,Biotech ETFs Jump on Roche-Spark Deal,Zacks
